ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2026
Cognitive profiles and predictors of cancer-related cognitive impairment in breast cancer survivors: integrating self-reported, neuropsychological, and process-based measures.
Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveCharacterizing cancer-related cognitive impairment (CRCI) remains challenging due to limitations in the sensitivity of neuropsychological tests and diagnostic criteria. This study aimed to (a) classify breast cancer survivors in CRCI groups using self-reported and neuropsychological categories; (b) explore whether CRCI is related to specific cognitive domains; (c) analyze if comorbid symptoms predict CRCI group membership; (d) study the correspondence between Montreal Cognitive Assessment (MoCA) and neuropsychological CRCI; and (e) explore cognitive profiles of CRCI groups considering Boston Process Approach (BPA) indices.
methodThis cross-sectional study included 82 breast cancer survivors undergoing treatment and presenting mild depressive symptoms. Self-reported CRCI was assessed using the PROMIS-CF 8a, neuropsychological CRCI was defined following recommended criteria. Participants were classified into four independent CRCI groups: (a) non-CRCI; (b) subjective CRCI; (c) objective CRCI; (d) combined CRCI. Logistic regression models examined predictors, χ2 tests assessed MoCA correspondence, and group differences in BPA indices were studied through ANOVA.
resultsParticipants' mean age was 47.76 years, 71.95% exhibited self-reported CRCI and 48.78% neuropsychological CRCI. Anxiety predicted subjective and combined CRCI, while lower self-efficacy predicted combined CRCI. MoCA showed limited sensitivity and specificity for neuropsychological CRCI. The combined CRCI group exhibited poorer quality of life and lower performance on processing speed and verbal fluency tasks.
conclusionsCRCI assessment should include self-reported and neuropsychological measures. MoCA should not replace comprehensive neuropsychological assessment, while BPA may provide complementary meaningful information to characterize CRCI profiles. CRCI interventions should target executive functioning, anxiety, and self-efficacy. Longitudinal studies with control groups are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.